MetaVia Inc.
MTVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001638287
No open-market purchases or sales by MetaVia Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $414.0K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in MetaVia Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +8 vs. Q3 2022
- Shares held
- 1.39M
- +1.38M (+8,556.3%) vs. Q3 2022
- Total value
- $1.00M
- +$780.8K (+355.7%) vs. Q3 2022
- New holders
- 10
- 4 more added
- Sold out
- 2
- 1 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MTVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $414.0K |
| Q1 2026 | 12 | $80.4K |
| Q4 2025 | 11 | $306.0K |
| Q3 2025 | 16 | $425.2K |
| Q2 2025 | 15 | $171.2K |
| Q1 2025 | 14 | $1.10M |
| Q4 2024 | 15 | $1.84M |
| Q3 2024 | 13 | $3.47M |
| Q2 2024 | 12 | $4.32M |
| Q1 2024 | 13 | $398.3K |
| Q4 2023 | 8 | $245.4K |
| Q3 2023 | 14 | $193.6K |
| Q2 2023 | 8 | $38.8K |
| Q1 2023 | 9 | $73.8K |
| Q4 2022 | 17 | $1.00M |
| Q3 2022 | 9 | $219.5K |
| Q2 2022 | 21 | $582.0K |
| Q1 2022 | 20 | $1.20M |
| Q4 2021 | 20 | $2.06M |
| Q3 2021 | 18 | $2.79M |
| Q2 2021 | 27 | $2.86M |
| Q1 2021 | 31 | $6.56M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding MetaVia Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 4 | $2 | 0.00% | +2+100.0% | Added |
| Group One Trading, L.P. | 3 | $2 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8 | $6 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 24 | $17 | 0.00% | +21+700.0% | Added |
| UBS Group AG | 3,627 | $2.61K | 0.00% | −138−3.7% | Reduced |
| Citigroup Inc | 4,175 | $3.00K | 0.00% | +4,175 | New |
| Tower Research Capital LLC (TRC) | 5,385 | $4.00K | 0.00% | +5,207+2,925.3% | Added |
| Virtu Financial LLC | 13,953 | $10.0K | 0.00% | +13,953 | New |
| Kingsview Wealth Management, LLC | 17,839 | $12.8K | 0.00% | +17,839 | New |
| Engineers Gate Manager LP | 19,693 | $14.1K | 0.00% | +19,693 | New |
| Squarepoint Ops LLC | 24,146 | $17.3K | 0.00% | +24,146 | New |
| BlackRock Inc. | 42,220 | $30.3K | 0.00% | +41,513+5,871.7% | Added |
| Millennium Management LLC | 45,429 | $33.0K | 0.00% | +45,429 | New |
| Two Sigma Investments, LP | 65,035 | $46.7K | 0.00% | +65,035 | New |
| Walleye Capital LLC | 95,000 | $68.2K | 0.00% | +95,000 | New |
| CVI Holdings, LLC | 215,045 | $154.3K | 0.02% | +215,045 | New |
| Sabby Management, LLC | 841,815 | $604.0K | 1.62% | +841,815 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −11,393−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −38−100.0% | Sold out |